Jolanta Harasiuk

Mitochondrial Modulation as a Therapeutic Entry Point in Neurodegeneration

It is argued that heterogeneity, rather than mitochondrial biology itself, determines therapeutic tractability, and mitochondrial modulation is unlikely to provide a universal disease-modifying strategy, but remains a useful, carefully targeted addition for patient groups identified by genetic or specific biological ma...